Consensus conference on acute bronchiolitis (IV) : Treatment of acute bronchiolitis. Review of scientific evidence
2009 Asociación Española de Pediatría. Published by Elsevier Espana. All rights reserved..
A review of the evidence on treatment of acute bronchiolitis is presented. There is sufficient evidence on the lack of effectiveness of most interventions tested in bronchiolitis. Apart from oxygen therapy, fluid therapy, aspiration of secretions and ventilation support, few treatment options will be beneficial. There are doubts about the efficacy of inhaled bronchodilators (salbutamol or adrenaline), with or without hypertonic saline solution, suggesting that these options should be selectively used as therapeutic trials in moderate-severe bronchiolitis. Heliox and non-invasive ventilation techniques, methylxanthine could be used in cases with respiratory failure, in patients with apnea, and surfactant and inhaled ribavirin in intubated critically ill patients. The available evidence does not recommend the use of oral salbutamol, subcutaneous adrenaline, anticholinergic drugs, inhaled or systemic corticosteroids, antibiotics, aerosolized o intravenous immunoglobulin, respiratory physiotherapy and others (nitric oxide, recombinant human deoxyribonuclease, recombinant interferon, nebulised furosemide and so on).
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2010 |
---|---|
Erschienen: |
2010 |
Enthalten in: |
Zur Gesamtaufnahme - volume:72 |
---|---|
Enthalten in: |
Anales de pediatria (Barcelona, Spain : 2003) - 72(2010), 4 vom: 04. Apr., Seite 285.e1-285.e42 |
Sprache: |
Spanisch |
---|
Weiterer Titel: |
Conferencia de Consenso sobre bronquiolitis aguda (IV): tratamiento de la bronquiolitis aguda. Revisión de la evidencia científica |
---|
Beteiligte Personen: |
González de Dios, J [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 24.08.2010 Date Revised 21.11.2013 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.anpedi.2009.12.010 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM19692765X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM19692765X | ||
003 | DE-627 | ||
005 | 20231223205521.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231223s2010 xx |||||o 00| ||spa c | ||
024 | 7 | |a 10.1016/j.anpedi.2009.12.010 |2 doi | |
028 | 5 | 2 | |a pubmed24n0656.xml |
035 | |a (DE-627)NLM19692765X | ||
035 | |a (NLM)20347407 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a spa | ||
100 | 1 | |a González de Dios, J |e verfasserin |4 aut | |
245 | 1 | 0 | |a Consensus conference on acute bronchiolitis (IV) |b Treatment of acute bronchiolitis. Review of scientific evidence |
246 | 3 | 3 | |a Conferencia de Consenso sobre bronquiolitis aguda (IV): tratamiento de la bronquiolitis aguda. Revisión de la evidencia científica |
264 | 1 | |c 2010 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 24.08.2010 | ||
500 | |a Date Revised 21.11.2013 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a 2009 Asociación Española de Pediatría. Published by Elsevier Espana. All rights reserved. | ||
520 | |a A review of the evidence on treatment of acute bronchiolitis is presented. There is sufficient evidence on the lack of effectiveness of most interventions tested in bronchiolitis. Apart from oxygen therapy, fluid therapy, aspiration of secretions and ventilation support, few treatment options will be beneficial. There are doubts about the efficacy of inhaled bronchodilators (salbutamol or adrenaline), with or without hypertonic saline solution, suggesting that these options should be selectively used as therapeutic trials in moderate-severe bronchiolitis. Heliox and non-invasive ventilation techniques, methylxanthine could be used in cases with respiratory failure, in patients with apnea, and surfactant and inhaled ribavirin in intubated critically ill patients. The available evidence does not recommend the use of oral salbutamol, subcutaneous adrenaline, anticholinergic drugs, inhaled or systemic corticosteroids, antibiotics, aerosolized o intravenous immunoglobulin, respiratory physiotherapy and others (nitric oxide, recombinant human deoxyribonuclease, recombinant interferon, nebulised furosemide and so on) | ||
650 | 4 | |a Consensus Development Conference | |
650 | 4 | |a English Abstract | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a Adrenal Cortex Hormones |2 NLM | |
650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
650 | 7 | |a Bronchodilator Agents |2 NLM | |
650 | 7 | |a Cholinergic Antagonists |2 NLM | |
650 | 7 | |a Saline Solution, Hypertonic |2 NLM | |
650 | 7 | |a Surface-Active Agents |2 NLM | |
650 | 7 | |a Helium |2 NLM | |
650 | 7 | |a 206GF3GB41 |2 NLM | |
650 | 7 | |a Ribavirin |2 NLM | |
650 | 7 | |a 49717AWG6K |2 NLM | |
650 | 7 | |a heliox |2 NLM | |
650 | 7 | |a 58933-55-4 |2 NLM | |
650 | 7 | |a Oxygen |2 NLM | |
650 | 7 | |a S88TT14065 |2 NLM | |
650 | 7 | |a Epinephrine |2 NLM | |
650 | 7 | |a YKH834O4BH |2 NLM | |
700 | 1 | |a Ochoa Sangrador, C |e verfasserin |4 aut | |
700 | 0 | |a Grupo de Revisión del Proyecto aBREVIADo (BRonquiolitis-Estudio de Variabilidad, Idoneidad y Adecuación) |e verfasserin |4 aut | |
700 | 1 | |a Andrés de Llano, Jesús M |e investigator |4 oth | |
700 | 1 | |a Aparicio Rodrigo, María |e investigator |4 oth | |
700 | 1 | |a Bajo Delgado, Ana Fe |e investigator |4 oth | |
700 | 1 | |a Balaguer, Albert |e investigator |4 oth | |
700 | 1 | |a Bonillo, Antonio |e investigator |4 oth | |
700 | 1 | |a Buñuel Alvarez, José Cristóbal |e investigator |4 oth | |
700 | 1 | |a Canut Blasco, Andrés |e investigator |4 oth | |
700 | 1 | |a Eiros Bouza, José María |e investigator |4 oth | |
700 | 1 | |a Fàbrega Sabaté, Jordi |e investigator |4 oth | |
700 | 1 | |a Fernández Alonso, José Elviro |e investigator |4 oth | |
700 | 1 | |a Fernández Rodríguez, Mercedes |e investigator |4 oth | |
700 | 1 | |a Lapeña López de Armentia, Santiago |e investigator |4 oth | |
700 | 1 | |a López Avila, Javier |e investigator |4 oth | |
700 | 1 | |a Molinos Norniella, Cristina |e investigator |4 oth | |
700 | 1 | |a Orejón de Luna, Gloria |e investigator |4 oth | |
700 | 1 | |a Todorcevic, Svetlana |e investigator |4 oth | |
700 | 1 | |a García-Puente Sánchez, María |e investigator |4 oth | |
700 | 1 | |a Muñoz Martín, Beatriz |e investigator |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Anales de pediatria (Barcelona, Spain : 2003) |d 2001 |g 72(2010), 4 vom: 04. Apr., Seite 285.e1-285.e42 |w (DE-627)NLM124027334 |x 1695-4033 |7 nnns |
773 | 1 | 8 | |g volume:72 |g year:2010 |g number:4 |g day:04 |g month:04 |g pages:285.e1-285.e42 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.anpedi.2009.12.010 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 72 |j 2010 |e 4 |b 04 |c 04 |h 285.e1-285.e42 |